GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
5XWU | Q64487 | Crystal structure of PTPdelta Ig1-Ig3 in complex with SALM2 LRR-Ig | |
5Y32 | Q64487 | Crystal structure of PTP delta Ig1-Ig2 in complex with IL1RAPL1 | |
7CEG | Q64487 | Crystal structure of the complex between mouse PTP delta and neuroligin-3 | |
4Y61 | Q64487 | Crystal structure of the complex between Slitrk2 LRR1 and PTP delta Ig1-Fn1 | |
4YFD | Q64487 | Crystal structure PTP delta Ig1-Fn2 in complex with IL-1RAcP | |
4YFG | Q64487 | Crystal structure of PTP delta meA3/meB minus variant Ig1-Fn1 | |
4YH7 | Q64487 | Crystal structure of PTPdelta ectodomain in complex with IL1RAPL1 | |
5XWT | Q64487 | Crystal structure of PTPdelta Ig1-Fn1 in complex with SALM5 LRR-Ig | |
2XR9 | Q64610 | Crystal structure of Autotaxin (ENPP2) | |
2XRG | Q64610 | Crystal structure of Autotaxin (ENPP2) in complex with the HA155 boronic acid inhibitor | |
5DLT | Q64610 | Crystal structure of Autotaxin (ENPP2) with 7-alpha-hydroxycholesterol | |
5DLV | Q64610 | Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA) | |
5DLW | Q64610 | Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA) and lysophosphatidic acid (LPA) | |
5IJQ | Q64610 | Crystal structure of autotaxin (ENPP2) re-refined | |
5IJS | Q64610 | Crystal structure of autotaxin with orthovanadate bound as a trigonal bipyramidal intermediate analog | |
5L0B | Q64610 | Crystal Structure of Autotaxin and Compound 1 | |
5L0E | Q64610 | Crystal Structure of Autotaxin and Compound 1 | |
5L0K | Q64610 | Crystal Structure of Autotaxin and Compound PF-8380 | |
5LQQ | Q64610 | Structure of Autotaxin (ENPP2) with LM350 | |
5M0D | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0E | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0M | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
5M0S | Q64610 | Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | |
9ENT | Q64610 | SSX structure of Autotaxin in cryogenic conditions | |
9EU5 | Q64610 | SSX structure of Autotaxin at room temperature | |
7Z0N | Q64610 | Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators | |
7P4J | Q64610 | Crystal structure of Autotaxin and tetrahydrocannabinol | |
7P4O | Q64610 | Crystal structure of Autotaxin and 9(R)-delta6a,10a-THC | |
7Z3K | Q64610 | Autotaxin in complex with orthosteric site-binder CpdA | |
7Z3L | Q64610 | Autotaxin in complex with hybrid compound ziritaxestat (GLPG1690) | |
5S9L | Q64610 | AUTOTAXIN, 4-[3-Oxo-3-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-propyl]-piperazine-1-carboxylic acid 3,5-dichloro-benzyl ester, 1.90A, P212121, Rfree=19.1% | |
5S9M | Q64610 | AUTOTAXIN, (3,5-dichlorophenyl)methyl (3aS,8aR)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,5,7,8,8a-octahydropyrrolo[3,4-d]azepine-6-carboxylate, 1.80A, P212121, Rfree=21.1% | |
5S9N | Q64610 | AUTOTAXIN, [4-(trifluoromethoxy)phenyl]methyl (3aS,6aS)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate, 1.80A, P212121, Rfree=23.3% | |
7P0K | Q64610 | Crystal structure of Autotaxin (ENPP2) with 18F-labeled positron emission tomography ligand | |
8C4W | Q64610 | Crystal structure of rat autotaxin and compound MEY-002 | |
8C7R | Q64610 | Crystal structure of rat autotaxin and compound MEY-003 | |
6U9W | Q64663 | Cryo electron microscopy structure of the ATP-gated rat P2X7 ion channel in the ATP-bound, open state | |
6U9V | Q64663 | Cryo electron microscopy structure of the ATP-gated rat P2X7 ion channel in the apo, closed state | P2X purinoceptor 7 |
8TR5 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in the apo closed state | |
8TRJ | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the high-affinity agonist BzATP | |
8V4S | Q64663 | Cryo-EM structure of the rat P2X7 receptor in the apo closed state purified in the absence of sodium | |
8TR6 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist A438079 | |
8TR7 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist A839977 | |
8TR8 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist AZD9056 | |
8TRA | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist GSK1482160 | |
8TRB | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist JNJ47965567 | |
8TRK | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist methyl blue | |
1UXB | Q64822 | ADENOVIRUS AD19p FIBRE HEAD in complex with sialyl-lactose | |
1UXA | Q64823 | ADENOVIRUS AD37 FIBRE HEAD in complex with sialyl-lactose | |
2WGT | Q64823 | Structure of human adenovirus serotype 37 fibre head in complex with a sialic acid derivative, O-Methyl 5-N-propaonyl-3,5-dideoxy-D- glycero-a-D-galacto-2-nonulopyranosylonic acid |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024